A dataset of digital therapeutic device approvals to support regulatory decisions and industry research
This paper presents a comprehensive dataset of digital therapeutic device approvals across four countries to aid regulatory decisions and industry analysis.
- Publisher
- Nature Publishing Group
- Published
- Length
- 27 pages
- File
- 997 KB PDF
Download the full 27-page PDF
Free · 997 KB · Instant access after email
This study constructs a standardized dataset of digital therapeutic (DTx) devices approved in the US, China, Germany, and Belgium, addressing the need for structured data in this rapidly evolving field.
Ready to read the full report?
Join 12,000+ pharma leaders getting deep industry analysis delivered weekly.
More whitepapers like this
Strategies to Enhance Recruitment of Female Participants to Cardiovascular Research
This consensus document outlines strategies to increase female representation in cardiovascular clinical trials, addressing significant under-representation of women.
British Society of Gastroenterology Guidelines on Inflammatory Bowel Disease in Adults: 2025
The updated BSG guidelines emphasize the necessity of ileocolonoscopy for IBD diagnosis and advocate for immunomodulators in all patients.
🔒 Agentic AI for Pharma Launches: Access & Engagement
Agentic AI can enhance pharma launches by improving market access and HCP engagement, with potential efficiency gains of up to 80%.